This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Caccavo, D. Articles by Jirillo, E. Search for Related Content PubMed PubMed Citation Articles by Caccavo, D. Articles by Jirillo, E. Social Bookmarking                   What's this?

Review: Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application

Department of `Clinica Medica, Immunologia e Malattie Infettive', University of Bari, Bari, Italy, caccavo{at}midim.uniba.it

Nelly M. Pellegrino

Department of `Clinica Medica, Immunologia e Malattie Infettive', University of Bari, Bari, Italy

Maria Altamura

Department of `Clinica Medica, Immunologia e Malattie Infettive', University of Bari, Bari, Italy

Amelia Rigon

University `Campus Bio-Medico', Rome, Italy

Luigi Amati

IRCCS for Gastroenterological Diseases, Castellana Grotte, Bari, Italy

Antonio Amoroso

Department of `Medicina Clinica', University of `La Sapienza', Rome, Italy

Emilio Jirillo

Department of `Clinica Medica, Immunologia e Malattie Infettive', University of Bari, Bari, Italy

Lactoferrin is an iron-binding glycoprotein present in various secretions (e.g. milk, tears, saliva, pancreatic juice, etc.). It is also stored in specific granules of polymorphonuclear granulocytes from which it is released following activation. Lactoferrin exerts a bactericidal activity by damagingthe outer membrane of Gram-negative bacteria, as well as immunoregulatory functions by decreasing the release of interleukin-1 (IL-1), IL-2 and tumor necrosis factor- (TNF-) and enhancing monocyte and natural killer cell cytotoxicity. Lactoferrin binds with high affinity to lipid A, the toxic moiety of the lipopolysaccharide, or endotoxin from Gram-negative bacteria. Lipopolysaccharide interaction with monocytes/macrophages results in the production and release of TNF- , that plays an important role in inducing septic shock. In this respect, it has recently been demonstrated that lactoferrin inhibits the lipopolysaccharide interaction with CD14 on monocytes/macrophages by competition with the lipopolysaccharide binding protein. Therefore, besides its bactericidal activity, lactoferrin may also act by neutralizing the toxic effects of lipopolysaccharide and this protective role against endotoxin lethal shock has been demonstrated in animal models. Moreover, in vitro and in vivo neutralization of endotoxin by a human lactoferrin-derived peptide was also reported and lactoferrin or lactoferrin-derived peptides could represent useful tools for the treatment of endotoxin-induced septic shock. The recent production and characterization of monoclonal antibodies against different epitopes of human lactoferrin, including monoclonal antibodies selectively neutralizinglactoferrin binding to lipid A, may allow a better elucidation of the consequence of lactoferrin-lipopolysaccharideinteraction.

Journal of Endotoxin Research, Vol. 8, No. 6, 403-417 (2002)
DOI: 10.1177/09680519020080060901


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?